FDA Inspection
Intertek USA Inc.Intertek USA Inc. – FDA Inspection, Mar 7, 2025
Record Details
This FDA Inspection record concerns Intertek USA Inc., with an inspection on March 7, 2025, issued by the New Jersey District Office, covering biologics.
View Company Profile
ID · e6965e1f-e11f-479a-9c29-88858d51ae2b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1263062
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 11Electronic records
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Intertek USA Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 25, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 21, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 12, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 21, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 3, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Intertek USA Inc.
- FDA Inspection 1286506 - 2025-09-25
- FDA Inspection 1135115 - 2020-12-21
- FDA Inspection 981650 - 2016-08-12
- FDA Inspection 815726 - 2013-01-21
- FDA Inspection 647477 - 2010-03-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.